See also this year's filing and all EDGAR filings for this company.
PDF Report 0001574774_2020_Biotelemetry_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Ignoring company because Assets is zero | pre-agg | {'balance_sheet': {'company_id': '0001574774', 'Assets': 0, 'AssetsCurrent': 0, 'AssetsNonCurrent': 0, 'CostOfGoodsAndServicesSold': 148986000, 'DepreciationDepletionAndAmortization': 0, 'Expenses': 349288000, 'GeneralAndAdministrativeExpense': 109736000, 'GoodwillImpairmentLoss': 0, 'IntangibleAssets': 0, 'LaborExpense': 0, 'Liabilities': 0, 'LiabilitiesCurrent': 0, 'LongTermLiabilities': 0, 'NetIncome': 41874000, 'OperatingCostsAndExpenses': 14659000, 'PropertyPlantAndEquipment': 0, 'ResearchAndDevelopmentExpense': 11206000, 'Revenues': 399472000, 'SellingAndMarketingExpense': 42849000, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 1316000, 'remainder_Expenses': 21852000, 'remainder_Liabilities': 0, 'remainder_NetIncome': -8310000, 'remainder_Revenues': 399472000, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001574774')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001574774, Biotelemetry INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 430,917,000 |
| 1 | AssetsNonCurrent | 17,464,000 |
| 2 | AssetsCurrent | 168,333,000 |
| 3 | PropertyPlantAndEquipment | 56,380,000 |
| 4 | remainder_Assets | 12,626,000 |
| 5 | LongTermLiabilities | 262,760,000 |
| 6 | LiabilitiesCurrent | 55,754,000 |
| 7 | remainder_Liabilities | 289,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 164,833,000 |
| 10 | GeneralAndAdministrativeExpense | 120,093,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 15,004,000 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 50,664,000 |
| 15 | ResearchAndDevelopmentExpense | 13,994,000 |
| 16 | remainder_Expenses | 31,652,000 |
| 17 | remainder_Revenues | 439,107,000 |
| 18 | remainder_NetIncome | -13,023,000 |
| 19 | remainder_ComprehensiveNetIncome | -725,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 685,720,000 |
| 1 | Liabilities | 318,803,000 |
| 2 | Expenses | 396,240,000 |
| 3 | Revenues | 439,107,000 |
| 4 | StockholdersEquity | 366,917,000 |
| 5 | NetIncome | 29,844,000 |
| 6 | ComprehensiveNetIncome | 29,119,000 |
| 7 | BaseVar | 926,809,000 |
| 8 | EconomicCapitalRatio | 2.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
